Denied

No. 15-560

Boehringer Ingelheim Pharmaceuticals, Inc. v. Federal Trade Commission

from the United States Court of Appeals for the District of Columbia Circuit

See other cases from the District of Columbia Circuit.

Docket Entries

Petition DENIED.

Reply of petitioner Boehringer Ingelheim Pharmaceuticals, Inc. filed. (Distributed)

DISTRIBUTED for Conference of January 15, 2016.

Brief of respondent Federal Trade Commission in opposition filed.

Brief amicus curiae of American Bar Association filed.

Order extending time to file response to petition to and including January 4, 2016.

Motion (15M42) for leave to file a petition for a writ of certiorari with the supplemental appendix under seal Granted.

MOTION (15M42) DISTRIBUTED for Conference of October 30, 2015.

Petition for a writ of certiorari filed. (Response due December 2, 2015)

Motion (15M42) for leave to file a petition for a writ of certiorari with the supplemental appendix under seal filed.

Application (15A208) granted by The Chief Justice extending the time to file until October 2, 2015.

Application (15A208) to extend the time to file a petition for a writ of certiorari from September 2, 2015 to October 2, 2015, submitted to The Chief Justice.

Parties

Boehringer Ingelheim Pharmaceuticals, Inc., Petitioner, represented by Lawrence D. Rosenberg

Federal Trade Commission, Respondent, represented by Donald B. Verrilli Jr.

Amici Curiae

American Bar Association, Amicus Curiae, represented by Paulette Brown

 
Last updated: March 27, 2017